{{Rsnum
|rsid=35390
|Gene=SLC45A2
|Chromosome=5
|position=33955221
|Orientation=plus
|GMAF=0.3182
|Gene_s=SLC45A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 15.9 | 45.5 | 38.6
| JPT | 9.1 | 52.3 | 38.6
| YRI | 25.0 | 50.0 | 25.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 15.9 | 45.5 | 38.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21983787
|Trait=None
|Title=Genome-wide association study identifies three new melanoma susceptibility loci.
|RiskAllele=
|Pval=2E-7
|OR=2.7800
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}